Skip Nav Destination
1-20 of 68
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach
Phoebe Tsz Man Cheng, BSc,MD, Diego Villa, MD MPH, R. Petter Tonseth, MD, David W. Scott, MBChB, PhD, Alina S Gerrie, MD MPH, Ciara L Freeman, MSc, MBBChir, Christina Aquino Parsons, MD, Tom Pickles, MD, Andrea Lo, MD, Don Wilson, MD, Brian Skinnider, MD, Laurie H Sehn, MD, Joseph M Connors, MD, Kerry J Savage, BSc, MD MSc
Blood (2019) 134 (Supplement_1): 2845.
Classical Hodgkin Lymphoma Patients Have an Increased Incidence of Idiopathic Acquired Aplastic Anemia
Taylor Linaburg, BSc, Adam R. Davis, MD, Noelle V. Frey, MD, Daniel J. Landsburg, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Yimei Li, PhD, Yuliya Borovskiy, MS, Timothy S. Olson, MD PhD, Adam Bagg, MD, Elizabeth O. Hexner, MD MS, Daria V. Babushok, MD PhD
Blood (2018) 132 (Supplement 1): 5098.
Erden Atilla, MD, Selami Kocak Toprak, MD, Sinem Civriz Bozdag, MD, Meltem Yuksel, MD, Pervin Topcuoglu, MD, Hamdi Akan, MD, Onder Arslan, MD, Taner Demirer, MD, Meral Beksac, MD, Osman Ilhan, MD, Muhit Ozcan, MD, Gunhan Gurman, MD
Blood (2017) 130 (Supplement 1): 5528.
Can We Improve the Predictive Value of Interim PET/CT Using a New Prognostic Model for Advanced Hodgkin Lymphoma?
Eldad J. Dann, MD, Osnat Bairey, MD, Rachel Bar-Shalom, MD, Tanya Mashiach, MSc, Elinor Barzilai, BSc, Abraham Korenberg, MD, Luiza Akria, MD, Tamar Tadmor, MD, Kalman Filanovsky, MD, Uri Abadi, MD, Olga Kagna, MD, Rosa Ruchlemer, MD, Neta Goldschmidt, MD, Netanel A. Horowitz, MD, David Lavie, MD, Dina Ben-Yehuda, MD, Ofer Shpilberg, MD, Ora B. Paltiel, MDM, MSc
Blood (2016) 128 (22): 3001.
Differences in Outcome of Patients with Syncytial Variant Hodgkin Lymphoma (HL) Compared with Typical Nodular Sclerosis HL
Tarsheen K. Sethi, MD MS, Van T Nguyen, MD, Shaoying Li, MD, David S Morgan, MD, John P. Greer, MD, Nishitha M Reddy, M.B.B.S.
Blood (2015) 126 (23): 1441.
Neutrophil - Lymphocyte Ratio (NLR) at Diagnosis Is an Independent Prognostic Factor in Patients with Nodular Sclerosis Hodgkin Lymphoma: Results of a Large Multicenter Study Involving 990 Patients
Alessia Bari, Luigi Marcheselli, Tamar Tadmor, Raffaella Marcheselli, Maria Christina Cox, MDPhD, Samantha Pozzi, Angela Ferrari, Luca Baldini, Paolo Gobbi, Massimo Federico, Aaron Polliack, Stefano Sacchi
Blood (2015) 126 (23): 3862.
Tarsheen K. Sethi, MD MS, Van T Nguyen, MD, David S Morgan, MD, John P. Greer, MD, Nishitha M Reddy, M.B.B.S.
Blood (2015) 126 (23): 2640.
Late Relapse in Hodgkin Lymphoma (HL): A Retrospective Analysis of Patients Enrolled on Clinical Trials at the Istituto Nazionale Tumori of Milan (INT-MI)
Simonetta Viviani, MD, Alberto Mussetti, MD, Oreste Di Bartolo, MD, Antonello Cabras, MD, Pinuccia Valagussa, Statistician, Gianni Bonadonna, MD, Alessandro M. Gianni, MD, Paolo Corradini, MD
Blood (2015) 126 (23): 2697.
Trend Analysis of Clinical Outcomes in Hodgkin Lymphoma over the Last Three Decades: Report from the Nebraska Lymphoma Study Group
Kailash Mosalpuria, MD MPH, Fausto R Loberiza, MD MS, R. Gregory Bociek, MD, Matthew A. Lunning, DO, Apar Kishor Ganti, MD, James Olen Armitage, MD, Julie M. Vose, MD, Philip Bierman, MD
Blood (2014) 124 (21): 1284.
Pediatric Hodgkin Lymphoma-Treatment Outcome with COPDac/ABVD Combination Chemotherapy – Single Institution Experience
Blood (2014) 124 (21): 5449.
Tiraje Celkan, Gül Nihal Özdemir, Hilal Akı, Hilmi Apak, Alp Özkan, Metin Hallaç, İbrahim Adaletli, Rahşan Özcan, Şefika Arzu Ergen, İnci Yıldız
Blood (2014) 124 (21): 5362.
Combined Modality Approach for Early Stage Unfavorable Hodgkin Lymphoma- Can We Avoid Radiation Therapy Based on Interim PET Imaging?
Blood (2014) 124 (21): 5430.
Genome-Wide DNA Methylation Analysis Reveals Epigenetic Deregulation of Key Biological Pathways in Therapy-Related Myeloid Neoplasms
Orsolya Lautner-Csorba, PhD, Jason Sotzen, Fabiani Emiliano, Fianchi Luana, Stefan Hohaus, MD, Giuseppe Leone, MD, Maria Teresa Voso, Maria E Figueroa, MD
Blood (2014) 124 (21): 3542.
Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder (HL-PTLD) after Solid Organ Transplant (SOT): A Comprehensive and Comparative Analysis of Disease Characteristics, Prognosis, and Survival
Blood (2014) 124 (21): 502.
Long-Term Follow-up Analysis of HD2000 Trial Comparing ABVD Versus BEACOPP Versus Copp/EBV/CAD in Patients with Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study from the Fondazione Italiana Linfomi
Francesco Merli, MD, Stefano Luminari, MD, Caterina Mammi, PhD, Nicola Cascavilla, MD, Alessia Bari, MD, Caterina Stelitano, MD, Renato Scalone, MD, Luca Baldini, Prof, Francesco Angrilli, MD, Giuseppe Polimeno, MD, Paolo G Gobbi, Prof, Giulia Cervetti, MD, Fiorella Ilariucci, MD, Alessia Ruffini, Luigi Marcheselli, Massimo Federico, MD
Blood (2014) 124 (21): 499.
Systematic Review and Individual Patient Data Meta-Analysis Of Treatment-Related Risk Of Secondary Malignant Neoplasms After Hodgkin Lymphoma
Blood (2013) 122 (21): 1753.
Absolut Lymphocyte Count At Diagnosis Is Predictive Of Survival In Patients With Classical Hodgkin Lymphoma: A Retrospective Multicenter Brazilian Study
Guilherme Fleury Perini, MD, Egyla M Cavalcante, MD, Joao Garibaldi Rezende, Jr., MD, Davimar Miranda Borducchi, MD, Fernanda Cunha Vieira, MD, Danielle Leão Cordeiro Faria, MD, MS, Renato S Tavares, MD, Camila Almeida Amaral, Fabio S P Santos, MD, Nelson Hamerschlak, MD, PhD, Karin Zattar Cecyn, Eni Maria Souza, M.D, PhD, Adriana M. Damasco Penna, M.D, Otavio C.G. Baiocchi, MD, PhD
Blood (2013) 122 (21): 4236.
Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Blood Stem-Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma: Excellent Disease Control and Long-Term Survival Rates
Ryan D. Gentzler, MD, MS, Andrew M. Evens, DO, MSc, Alfred W. Rademaker, PhD, Bharat B Mittal, M.D., Adam M. Petrich, MD, Jessica K. Altman, MD, Olga Frankfurt, MD, Daina Variakojis, MD, Seema Singhal, M.D., Jayesh Mehta, MD, Joel R Green, MD, Stephanie Williams, MD, Lynne Kaminer, MD, Leo I. Gordon, MD, Jane N. Winter, MD
Blood (2012) 120 (21): 2024.
Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution
Saad J. Sirop, MD, Thomas M Habermann, MD, William R Macon, MD, Kay M. Ristow, Stephen M Ansell, MD, PhD, Joseph P Colgan, MD, Patrick B. Johnston, MD, PhD, David J. Inwards, MD, Svetomir N. Markovic, MD, PhD, Ivana N. Micallef, MD, Carrie Thompson, MD, Luis F. Porrata, MD, James A. Martenson, Jr., MD, James R Cerhan, MD, PhD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD
Blood (2012) 120 (21): 1525.
Camila C.G. Linardi, MD; PhD., Luis Fernando Pracchia, MD., Rodrigo Dolphini Velasques, MD., Claudia Bitti Barroso, MD, Valeria Buccheri, MD; PhD.
Blood (2011) 118 (21): 3153.